Coronary disease

Coronary Events Following TAVI: A Registry

Between 30 and 70% of patients undergoing transcatheter aortic valve replacement (TAVR) present coronary artery disease (CAD)....

Dr. Andrés Rodríguez - 21 July, 2025

Learn More

Chronic Coronary Syndromes

Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

Physiology guided revascularization has been shown to improve clinical outcomes vs. conventional angiography. However, after percutaneous coronary...

Dr. Omar Tupayachi - 16 July, 2025

Learn More

Coronary disease

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

The development of bioresorbable magnesium scaffolds (RMS) has generated significant expectation in the field of percutaneous coronary...

Dr. Omar Tupayachi - 3 July, 2025

Learn More

Acute coronary syndromes

Early Discharge After STEMI: Clinical Benefit and Cost-Effectiveness?

Improvements in reperfusion strategies for ST-segment elevation myocardial infarction (STEMI) have transformed the prognosis for this condition....

Dr. Omar Tupayachi - 26 June, 2025

Learn More

Chronic Ischemic cardiopathy

Can Intense Exercise Modify the Coronary Atherosclerosis Profile?

While physical activity is a widely accepted recommendation for preventing cardiovascular disease, questions remain regarding the impact...

Dr. Juan Manuel Pérez - 26 June, 2025

Learn More

Chronic Coronary Syndromes

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which...

Dr. Omar Tupayachi - 20 June, 2025

Learn More

Chronic Coronary Syndromes

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an...

Dr. Omar Tupayachi - 17 June, 2025

Learn More

Acute coronary syndromes

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to...

Dr. Andrés Rodríguez - 11 June, 2025

Learn More

Coronary disease

Coronary Events Following TAVI: A Registry

Variability of Coronary Physiology (FFR/iFR) in Diffuse Tandem Lesions

OCT Assessment of Bioresorbable Scaffold Performance across Different Types of Plaque

Early Discharge After STEMI: Clinical Benefit and Cost-Effectiveness?

Can Intense Exercise Modify the Coronary Atherosclerosis Profile?

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

Chronic Stent Recoil and Its Long-Term Effects

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Last News

Coronary Perforations and Use of Covered Stents: Safe and Effective Long-Term Strategy?

Is it really necessary to monitor all patients after TAVR?

Is it really necessary to monitor all patients after TAVR?

Institutional News

Watch Again: Pulmonary Embolism in 2025 — Risk Stratification and Novel Therapeutic Approaches

Watch Again: SELUTION – Sirolimus-Eluting Balloon for De Novo Coronary Lesions – New Evidence and Clinical Perspectives

25/11 – SOLACI Webinar: Pulmonary Embolism in 2025 – Risk Stratification and Novel Therapeutic Approaches

Access